Highlights

  • Apple contests ban on Apple Watch imports amid patent dispute.
  • Legal battle intensifies between Apple and medical tech company Masimo.

Latest news

Asus Pad T3201 Review: OLED Brilliance Meets Everyday Mid-Range Power

Asus Pad T3201 Review: OLED Brilliance Meets Everyday Mid-Range Power

Qualcomm Showcases Snapdragon 8 Elite Gen 6 Chips At IMC 2026, Teases New Flagships

Qualcomm Showcases Snapdragon 8 Elite Gen 6 Chips At IMC 2026, Teases New Flagships

Shokz Diwali Sale Brings Discounts On Open-Ear Headphones Across Amazon And Flipkart

Shokz Diwali Sale Brings Discounts On Open-Ear Headphones Across Amazon And Flipkart

iQOO 16 Confirmed For India With Snapdragon 8 Elite Extreme Gen 6 And OriginOS 7

iQOO 16 Confirmed For India With Snapdragon 8 Elite Extreme Gen 6 And OriginOS 7

ASUS Announces Festive Discounts Across Laptops, Gaming PCs And Tablets

ASUS Announces Festive Discounts Across Laptops, Gaming PCs And Tablets

Priyanka Gandhi lies on ground, Rahul detained as Delhi Police stop INDIA bloc MPs' Jantar Mantar march

Priyanka Gandhi lies on ground, Rahul detained as Delhi Police stop INDIA bloc MPs' Jantar Mantar march

Emotion, tears as Messi retires from Argentina national team

Emotion, tears as Messi retires from Argentina national team

Rajpal Yadav tells CJI Surya Kant his legal troubles inspired film title ‘Solah Sawan Jhel Ke’

Rajpal Yadav tells CJI Surya Kant his legal troubles inspired film title ‘Solah Sawan Jhel Ke’

Apple puts emergency request to stop US watch import ban

The prohibition, sparked by Masimo's allegations of Apple integrating its pulse oximetry tech into the Apple Watch and violating patents, impacts Apple's Series 9 and Ultra 2 smartwatches featuring blood-oxygen monitoring features.

Apple puts emergency request to stop US watch import ban

As per a Reuters report, Apple has taken action in response to a recent decision by the U.S. International Trade Commission (ITC) to impose a ban on the import and sales of certain Apple Watches in the United States. This move follows a complaint filed by medical monitoring technology company Masimo, alleging patent infringement by Apple.

The ban, initiated after Masimo accused Apple of incorporating its pulse oximetry technology into the Apple Watch and infringing on its patents, affects Apple's Series 9 and Ultra 2 smartwatch models, which include blood-oxygen level monitoring capabilities.

Despite efforts by Apple to appeal the decision, including an emergency request filed with the U.S. Court of Appeals for the Federal Circuit, the company faced setbacks as the ITC's ruling remained in place. Apple’s plea for a halt in the ban until a decision on redesigned watch versions' patent infringement was rejected.

In response to the ban, Apple temporarily ceased the sale of the affected smartwatch models in the U.S. market but clarified that its Apple Watch SE and previously sold watches remain unaffected. The company has also continued to sell the banned models through various retailers like Amazon, Best Buy, and Walmart.

This legal battle highlights the intensity of intellectual property disputes within the tech industry, with Masimo asserting that Apple recruited its employees and unlawfully integrated its technology into the Apple Watch. However, Apple has contested these claims, emphasizing its disagreement with the ITC's decision and expressing its commitment to resolving the issue to ensure the return of the affected products to customers as soon as possible, reported Reuters.

The situation underscores the complexities of patent disputes between tech giants and smaller companies, indicating a potentially protracted legal process ahead. Analysts predict that an Apple appeal could prolong the final resolution by approximately another year, impacting the availability of the banned Apple Watch models in the U.S. market.

Apple's wearable technology business, which encompasses products like the Apple Watch and AirPods, has been a significant revenue driver for the company, generating billions in revenue during the third quarter of 2023, reported Reuters.


Also Watch: Apple's iPhone 17 may be developed in India: Report

Frequently Asked Questions

Apple temporarily ceased the sale of the affected models in the U.S. market but continued to sell them through various retailers like Amazon, Best Buy, and Walmart.

ADVERTISEMENT

Up Next

Apple puts emergency request to stop US watch import ban

Apple puts emergency request to stop US watch import ban

Sensex falls 429 points, Nifty slips 173 points after RBI rate hike

Sensex falls 429 points, Nifty slips 173 points after RBI rate hike

RBI raises repo rate by 25 bps to 5.50%, shifts policy towards tightening

RBI raises repo rate by 25 bps to 5.50%, shifts policy towards tightening

GST rates likely unchanged as 57th Council meeting focuses on reforms

GST rates likely unchanged as 57th Council meeting focuses on reforms

Sensex gains 685 points, Nifty rises 220 points to cross 22,700

Sensex gains 685 points, Nifty rises 220 points to cross 22,700

Sensex gains 473 points, Nifty rises 134 points as markets stage recovery

Sensex gains 473 points, Nifty rises 134 points as markets stage recovery

ADVERTISEMENT

editorji-whatsApp

More videos

India To Grow 7% In FY27, Next Growth Phase Hinges On Infra, Deeper Capital Markets: S&P Global

India To Grow 7% In FY27, Next Growth Phase Hinges On Infra, Deeper Capital Markets: S&P Global

Sensex Falls 49 Points, Nifty Slips 96 As Selling Pressure Returns

Sensex Falls 49 Points, Nifty Slips 96 As Selling Pressure Returns

Sensex falls 243 points, Nifty slips 64 points as foreign outflows and crude prices weigh

Sensex falls 243 points, Nifty slips 64 points as foreign outflows and crude prices weigh

India launches anti-dumping probes into 7 Chinese products, including key pharma ingredients

India launches anti-dumping probes into 7 Chinese products, including key pharma ingredients

Sensex crashes 1,124 points, Nifty falls 1.56% as crude surges above $107

Sensex crashes 1,124 points, Nifty falls 1.56% as crude surges above $107

Sensex Rises 315 Points, Nifty Gains 77 as Markets Recover After Sharp Sell-Off

Sensex Rises 315 Points, Nifty Gains 77 as Markets Recover After Sharp Sell-Off

Sensex Crashes 1,248 Points, Nifty Falls 1.64% Amid Global Cues

Sensex Crashes 1,248 Points, Nifty Falls 1.64% Amid Global Cues

Sensex, Nifty End Higher As Domestic Growth Signals, Softer Crude Support Sentiment

Sensex, Nifty End Higher As Domestic Growth Signals, Softer Crude Support Sentiment

UPI Payments In Uzbekistan: Indian Travellers To Get QR-Based Payment Option

UPI Payments In Uzbekistan: Indian Travellers To Get QR-Based Payment Option

India’s Q1 GDP Growth Hits 7.8%, Beats RBI Estimate

India’s Q1 GDP Growth Hits 7.8%, Beats RBI Estimate

Editorji Technologies Pvt. Ltd. © 2022 All Rights Reserved.